Digital Social pharma faces: Gary Monk (part 2) Continuing our pharma social media interview series, watch the second part of our interview with Gary Monk and hear his thoughts on the future of digi
Digital Social pharma faces: Gary Monk (part I) As the first piece in a new series of interviews with some key people in pharma social media, pharmaphorum managed to catch up with Gary Monk for his
News Lilly wins new FDA approval for eczema drug Ebglyss Lilly's Ebglyss has claimed an FDA approval for less-frequent maintenance dosing that could give it an edge over market leader Dupixent.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.